Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Apyx Medical (APYX) Accumulated Depreciation & Amortization (2016 - 2025)

Apyx Medical's Accumulated Depreciation & Amortization history spans 15 years, with the latest figure at $4.1 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 23.17% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $4.1 million, up 23.17%, while the annual FY2025 figure was $4.1 million, 23.17% up from the prior year.
  • Accumulated Depreciation & Amortization reached $4.1 million in Q4 2025 per APYX's latest filing, up from $3.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $4.1 million in Q4 2025 to a low of $157000.0 in Q1 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $891437.5, with a median of $506000.0 recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: decreased 25.0% in 2023, then skyrocketed 384.68% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $903000.0 in 2021, then dropped by 1.44% to $890000.0 in 2022, then decreased by 22.25% to $692000.0 in 2023, then surged by 384.68% to $3.4 million in 2024, then increased by 23.17% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Accumulated Depreciation & Amortization are $4.1 million (Q4 2025), $3.4 million (Q4 2024), and $313000.0 (Q2 2024).